Replies to post #80606 on Biotech Values

[DewDiligence]

Re: My ARYX Tecarfarin prediction (from April)

Suffice it to say, your prediction looks safe now. Notwithstanding, the company is still apparently going to try and partner the compound so maybe you're not out of the woods yet. LOL

I don’t care if they do partner it (unlikely as this may be). Tecarfarin won’t sell no matter who owns it because the underlying premise for the program is misguided.

Thanks for taking note of my prediction. You were wise to append the “LOL” above, LOL.